Written question asked by Esther McVey (Conservative) on Friday, 4 October 2024, in the House of Commons. It was due for an answer on Tuesday, 8 October 2024. It was answered by Andrew Gwynne (Labour) on Monday, 14 October 2024 on behalf of the Department of Health and Social Care.
Coronavirus: Vaccination
- Question
-
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential implications for his policies of the study entitled Risk of all-cause and cardiac-related mortality after vaccination against COVID-19: A meta-analysis of self-controlled case series studies, published on 3 August 2023.
- Answer
-
All vaccines used in the United Kingdom are only authorised once they have met the robust standards of effectiveness, safety, and quality set by the UK’s independent regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).
The monitoring of vaccine safety does not stop once a vaccine has been approved. Whilst no specific assessment has been made of this study, the MHRA continuously monitors safety data from a range of sources including Yellow Card reports, interim and final study reports for clinical trials, post-authorisation safety studies, and data from scientific literature.
Secondary information
- Type
- Written question
- Reference
- 6194
- Session
- 2024-26
- Related items
- Subjects
- Heart diseases Coronavirus Vaccination
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2025-11-04 13:48:23 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/6194
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/6194
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/6194